Importantly, EGCG inhibits the expression of O6-Methylguanine DNA-Methyltransferase (MGMT) in GBM-derived cells only, which is an essential regulator of the resistance to temozolomide (TMZ) in glioblastomas. The gene discussed is MGMT; the disease is glioblastoma.